A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.
Deep Learning Helps Predict Treatment Response in Muscle-Invasive Bladder Cancer
June 10, 2025
Deep Learning Helps Predict Treatment Response in Muscle-Invasive Bladder Cancer
AI, Cancer, and HIV An interview with Dr. Olivier Elemento
June 10, 2025
Olivier Elemento, PhD, is Director of the Englander Institute for Precision Medicine and Associate Director of the Institute for Computational Biomedicine at Weill Cornell Medicine. His research group combines big data and artificial intelligence with experimentation and genomic profiling to accelerate the discovery of cancer cures. amfAR VP and Director of Research Andrea Gramatica, PhD, spoke with Dr. Elemento about his work and its potential applications in HIV research.
Treatment switch, liquid biopsy improve breast cancer outcomes
June 10, 2025
A large prospective randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.
June 2025 EIPM Director's Memo
June 10, 2025
June 2025 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
I hope you enjoy reading about our recent departmental accomplishments, including news media coverage of our work, participation in major conferences & meetings, and impressive publications in top-tier journals like The New England Journal of Medicine, Nature Communications, and Science Signalingby a range of EIPM colleagues.
Thank you again for your continued hard work and dedication to our mission.
Sincerely,
Three-Dimensional Gene Hubs May Promote Brain Cancer
April 22, 2025
The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers.
New Strategy May Enable Cancer Monitoring from Blood Tests Alone
April 11, 2025
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.
EIPM's 1Q 2025 External Newsletter
April 3, 2025
EIPM's First Quarter 2025 External NewsletterMemo
March 31, 2025
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our first quarterly external newsletter of 2025!
April 2025 EIPM Director's Memo
April 3, 2025
April 2025 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,